Popularity of Ozempic and Wegovy among privately insured patients may worsen disparities, suggests study​Popularity of Ozempic and Wegovy among privately insured patients may worsen disparities, suggests study 

A USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with private insurance. ​A USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less Read More

Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases​Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases 

This qualitative study assesses the quality, amount of active ingredient, and characteristics associated with counterfeiting of semaglutide purchased from illegal online pharmacies without a prescription. ​This qualitative study assesses the quality, amount of active ingredient, and characteristics associated with counterfeiting of semaglutide purchased from illegal online pharmacies without a prescription. 

Study indicates surge in GLP-1RA prescriptions to treat obesity and prevent its complications​Study indicates surge in GLP-1RA prescriptions to treat obesity and prevent its complications 

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States. ​Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like Read More

Semaglutide leads to greater weight loss in women than men with HF and improves HF symptoms​Semaglutide leads to greater weight loss in women than men with HF and improves HF symptoms 

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options. Women experienced greater weight loss and the same symptom benefits compared with men. ​Semaglutide, a medication initially developed for type 2 diabetes and obesity, Read More

Stop criticising Ozempic – it could be a solution to more than obesity​Stop criticising Ozempic – it could be a solution to more than obesity 

Weight-loss drugs are proving their worth against addiction, high blood pressure and even depression, so let’s stop criticising them as a quick fix and start exploring their true potential ​Weight-loss drugs are proving their worth against addiction, high blood pressure and even depression, so let’s stop criticising them as a quick fix and start exploring Read More